Heart Disease News and Research

Latest Heart Disease News and Research

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

Trial addresses the optimal timing for complete revascularization of patients with STEMI and multivessel disease

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

ECLS does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock

Fat-filled lipid droplets may be a potential threat to cell's nucleus

Fat-filled lipid droplets may be a potential threat to cell's nucleus

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Study shows efficacy and safety of OCT-guided strategy for percutaneous coronary intervention

Acoramidis shows potential to be effective, safe treatment for transthyretin amyloid cardiomyopathy

Acoramidis shows potential to be effective, safe treatment for transthyretin amyloid cardiomyopathy

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Ablation more effective than medical therapy in patients with end-stage heart failure, study shows

Ablation more effective than medical therapy in patients with end-stage heart failure, study shows

Physiology-guided complete revascularization reduces ischemic events in older MI patients

Physiology-guided complete revascularization reduces ischemic events in older MI patients

ARREST trial results question need to transport all cardiac arrest patients to centers

ARREST trial results question need to transport all cardiac arrest patients to centers

First oral treatment for Lipoprotein(a) shows significant cholesterol reduction

First oral treatment for Lipoprotein(a) shows significant cholesterol reduction

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing

CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing

Intravenous ferric carboxymaltose linked to lower risk of heart failure hospitalizations in iron-deficient patients

Intravenous ferric carboxymaltose linked to lower risk of heart failure hospitalizations in iron-deficient patients

PROFID EHRA trial to assess the potential benefit of ICD therapy in myocardial infarction survivors

PROFID EHRA trial to assess the potential benefit of ICD therapy in myocardial infarction survivors

The potential of targeting mitochondria-associated programmed cell death for age-related disease treatment

The potential of targeting mitochondria-associated programmed cell death for age-related disease treatment

Trial evaluates behavioral and psychological interventions to reduce cardiotoxic effects of breast cancer treatment

Trial evaluates behavioral and psychological interventions to reduce cardiotoxic effects of breast cancer treatment

Study shows benefit of traditional Chinese medicine for heart failure

Study shows benefit of traditional Chinese medicine for heart failure

Research links hypertensive disorders of pregnancy with dementia

Research links hypertensive disorders of pregnancy with dementia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.